Ani Pharmaceuticals Inc (ANIP)
Cost of Revenue
$340.18M
TTM · Period ending: · USD
ANIP Cost of Revenue
Latest reported$340.18Mperiod ending
Latest reported$340.18Mperiod ending
ANIP TTM Cost of Revenue ($0.00 → $340.18M)
TTM cost of revenue
High-resolution chart · PNG
ANIP cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 340,180,000 | |
| 314,637,000 | |
| 273,173,000 | |
| 343,953,000 | |
| 291,007,000 | |
| 274,090,000 | |
| 250,210,000 | |
| 223,350,000 | |
| 208,376,000 | |
| 192,962,000 | |
| 181,513,000 | |
| 164,419,000 | |
| 149,212,000 | |
| 142,222,000 | |
| 138,785,000 | |
| 136,357,000 | |
| 127,876,000 | |
| 114,896,000 | |
| 100,610,000 | |
| 91,252,000 | |
| 86,957,000 | |
| 85,338,000 | |
| 87,157,000 | |
| 80,412,000 | |
| 75,296,000 | |
| 70,233,000 | |
| 63,154,000 | |
| 65,492,000 | |
| 66,095,000 | |
| 67,056,000 | |
| 73,024,000 | |
| 73,337,000 | |
| 78,810,000 | |
| 83,339,000 | |
| 79,032,000 | |
| 75,492,000 | |
| 71,083,000 | |
| 61,756,000 | |
| 48,780,000 | |
| 35,414,000 | |
| 22,005,000 | |
| 13,351,000 | |
| 12,692,000 | |
| 12,825,000 | |
| 12,626,000 | |
| 11,602,000 | |
| 11,473,000 | |
| 10,484,000 | |
| 10,052,119 | |
| 10,033,659 | |
| 9,819,659 | |
| 10,010,282 | |
| 9,702,936 | |
| 7,604,396 | |
| 5,196,396 | |
| 2,371,773 | |
| 50,000 | |
| 50,000 | |
| 50,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |